Sunshine Biopharma, Inc. (NASDAQ: SBFMW) Stock Competitors & Peer Comparison
See SBFMW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SBFMW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SBFMW | $0.04 | +0.00% | 175.2K | N/A | -$11.30 | N/A |
| RPRX | $56.77 | -0.86% | 25.2B | 10.81 | $5.25 | +1.60% |
| CORT | $110.77 | +2.61% | 12B | 316.49 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $90.22 | +0.89% | 8B | 644.43 | $0.14 | N/A |
| KNSA | $76.06 | -0.59% | 5.8B | 84.51 | $0.90 | N/A |
| TRLV | $8.75 | -2.78% | 1.5B | -20.83 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| CUVL | $6.68 | -0.65% | 336.6M | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
SBFMW vs RPRX Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, RPRX has a market cap of 25.2B. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while RPRX trades at $56.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas RPRX's P/E ratio is 10.81. In terms of profitability, SBFMW's ROE is -0.26%, compared to RPRX's ROE of +0.11%. Regarding short-term risk, SBFMW is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
SBFMW vs CORT Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, CORT has a market cap of 12B. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while CORT trades at $110.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas CORT's P/E ratio is 316.49. In terms of profitability, SBFMW's ROE is -0.26%, compared to CORT's ROE of +0.08%. Regarding short-term risk, SBFMW is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
SBFMW vs WBA Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas WBA's P/E ratio is -1.64. In terms of profitability, SBFMW's ROE is -0.26%, compared to WBA's ROE of -0.42%. Regarding short-term risk, SBFMW is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
SBFMW vs LQDA Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, LQDA has a market cap of 8B. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while LQDA trades at $90.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas LQDA's P/E ratio is 644.43. In terms of profitability, SBFMW's ROE is -0.26%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, SBFMW is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
SBFMW vs KNSA Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, KNSA has a market cap of 5.8B. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while KNSA trades at $76.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas KNSA's P/E ratio is 84.51. In terms of profitability, SBFMW's ROE is -0.26%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, SBFMW is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check KNSA's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
SBFMW vs TRLV Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, TRLV has a market cap of 1.5B. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while TRLV trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas TRLV's P/E ratio is -20.83. In terms of profitability, SBFMW's ROE is -0.26%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, SBFMW is more volatile compared to TRLV. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check TRLV's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
SBFMW vs HROWL Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas HROWL's P/E ratio is N/A. In terms of profitability, SBFMW's ROE is -0.26%, compared to HROWL's ROE of -0.34%. Regarding short-term risk, SBFMW is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
SBFMW vs HROWM Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas HROWM's P/E ratio is N/A. In terms of profitability, SBFMW's ROE is -0.26%, compared to HROWM's ROE of -0.34%. Regarding short-term risk, SBFMW is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check HROWM's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
SBFMW vs CUVL Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, CUVL has a market cap of 336.6M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while CUVL trades at $6.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas CUVL's P/E ratio is N/A. In terms of profitability, SBFMW's ROE is -0.26%, compared to CUVL's ROE of N/A. Regarding short-term risk, SBFMW is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check CUVL's competition here
LifeMD, Inc. (NASDAQ: LFMD)
SBFMW vs LFMD Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, LFMD has a market cap of 172.2M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while LFMD trades at $3.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas LFMD's P/E ratio is -7.12. In terms of profitability, SBFMW's ROE is -0.26%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, SBFMW is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check LFMD's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
SBFMW vs LFMDP Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, LFMDP has a market cap of 160M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while LFMDP trades at $23.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas LFMDP's P/E ratio is -722.96. In terms of profitability, SBFMW's ROE is -0.26%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, SBFMW is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check LFMDP's competition here
Circle8 Group, Inc. (NASDAQ: CIRC)
SBFMW vs CIRC Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, CIRC has a market cap of 65.1M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while CIRC trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas CIRC's P/E ratio is -1.64. In terms of profitability, SBFMW's ROE is -0.26%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, SBFMW is more volatile compared to CIRC. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check CIRC's competition here
Rite Aid Corporation (NYSE: RAD)
SBFMW vs RAD Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas RAD's P/E ratio is -0.05. In terms of profitability, SBFMW's ROE is -0.26%, compared to RAD's ROE of +2.76%. Regarding short-term risk, SBFMW is more volatile compared to RAD. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
SBFMW vs GLTO Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas GLTO's P/E ratio is -1.78. In terms of profitability, SBFMW's ROE is -0.26%, compared to GLTO's ROE of -1.22%. Regarding short-term risk, SBFMW is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check GLTO's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
SBFMW vs SCYX Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, SCYX has a market cap of 33M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while SCYX trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas SCYX's P/E ratio is -1.53. In terms of profitability, SBFMW's ROE is -0.26%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, SBFMW is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check SCYX's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
SBFMW vs NSRX Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, NSRX has a market cap of 29.8M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while NSRX trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas NSRX's P/E ratio is -4.80. In terms of profitability, SBFMW's ROE is -0.26%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, SBFMW is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check NSRX's competition here
Stablecoin Development Corp. (AMEX: SDEV)
SBFMW vs SDEV Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, SDEV has a market cap of 28.2M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while SDEV trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas SDEV's P/E ratio is -0.18. In terms of profitability, SBFMW's ROE is -0.26%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, SBFMW is more volatile compared to SDEV. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check SDEV's competition here
Biofrontera Inc. (NASDAQ: BFRI)
SBFMW vs BFRI Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, BFRI has a market cap of 16.3M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while BFRI trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas BFRI's P/E ratio is -1.19. In terms of profitability, SBFMW's ROE is -0.26%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, SBFMW is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
SBFMW vs CJJD Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas CJJD's P/E ratio is -0.46. In terms of profitability, SBFMW's ROE is -0.26%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, SBFMW is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
SBFMW vs SSY Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas SSY's P/E ratio is -2.86. In terms of profitability, SBFMW's ROE is -0.26%, compared to SSY's ROE of -0.09%. Regarding short-term risk, SBFMW is more volatile compared to SSY. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
SBFMW vs POM Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, POM has a market cap of 5.9M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while POM trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas POM's P/E ratio is -0.17. In terms of profitability, SBFMW's ROE is -0.26%, compared to POM's ROE of +0.16%. Regarding short-term risk, SBFMW is more volatile compared to POM. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check POM's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
SBFMW vs PAVS Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, PAVS has a market cap of 5.3M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while PAVS trades at $6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas PAVS's P/E ratio is -0.07. In terms of profitability, SBFMW's ROE is -0.26%, compared to PAVS's ROE of -0.27%. Regarding short-term risk, SBFMW is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check PAVS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
SBFMW vs HKPD Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, HKPD has a market cap of 4.6M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while HKPD trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas HKPD's P/E ratio is -7.01. In terms of profitability, SBFMW's ROE is -0.26%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, SBFMW is more volatile compared to HKPD. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check HKPD's competition here
AIxCrypto Holdings, Inc. (NASDAQ: AIXC)
SBFMW vs AIXC Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, AIXC has a market cap of 4.3M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while AIXC trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas AIXC's P/E ratio is -0.09. In terms of profitability, SBFMW's ROE is -0.26%, compared to AIXC's ROE of -0.94%. Regarding short-term risk, SBFMW is more volatile compared to AIXC. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check AIXC's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
SBFMW vs MDVL Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas MDVL's P/E ratio is -0.05. In terms of profitability, SBFMW's ROE is -0.26%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, SBFMW is more volatile compared to MDVL. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
SBFMW vs ATNFW Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas ATNFW's P/E ratio is N/A. In terms of profitability, SBFMW's ROE is -0.26%, compared to ATNFW's ROE of -2.41%. Regarding short-term risk, SBFMW is more volatile compared to ATNFW. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
SBFMW vs BGMSP Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, SBFMW's ROE is -0.26%, compared to BGMSP's ROE of -0.51%. Regarding short-term risk, SBFMW is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check BGMSP's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
SBFMW vs BGMS Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, BGMS has a market cap of 2M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while BGMS trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas BGMS's P/E ratio is -0.26. In terms of profitability, SBFMW's ROE is -0.26%, compared to BGMS's ROE of -0.51%. Regarding short-term risk, SBFMW is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check BGMS's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
SBFMW vs AZNH Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas AZNH's P/E ratio is 38.35. In terms of profitability, SBFMW's ROE is -0.26%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, SBFMW is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
SBFMW vs LFLYW Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, SBFMW's ROE is -0.26%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, SBFMW is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check LFLYW's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
SBFMW vs ESRX Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, ESRX has a market cap of 0. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas ESRX's P/E ratio is 10.69. In terms of profitability, SBFMW's ROE is -0.26%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, SBFMW is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check ESRX's competition here
POZEN Inc. (NASDAQ: POZN)
SBFMW vs POZN Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, POZN has a market cap of 0. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas POZN's P/E ratio is N/A. In terms of profitability, SBFMW's ROE is -0.26%, compared to POZN's ROE of +0.61%. Regarding short-term risk, SBFMW is more volatile compared to POZN. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check POZN's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
SBFMW vs OREX Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, OREX has a market cap of 0. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas OREX's P/E ratio is -0.14. In terms of profitability, SBFMW's ROE is -0.26%, compared to OREX's ROE of -0.54%. Regarding short-term risk, SBFMW is more volatile compared to OREX. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check OREX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
SBFMW vs IPXL Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, IPXL has a market cap of 0. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas IPXL's P/E ratio is -10.11. In terms of profitability, SBFMW's ROE is -0.26%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, SBFMW is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check IPXL's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
SBFMW vs CPD Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, CPD has a market cap of 0. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas CPD's P/E ratio is N/A. In terms of profitability, SBFMW's ROE is -0.26%, compared to CPD's ROE of N/A. Regarding short-term risk, SBFMW is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check CPD's competition here
Shire plc (NASDAQ: SHPG)
SBFMW vs SHPG Comparison August 2026
Sunshine Biopharma, Inc. (NASDAQ: SBFMW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SBFMW stands at 175.2K. In comparison, SHPG has a market cap of 0. Regarding current trading prices, SBFMW is priced at $0.04 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SBFMW currently has a P/E ratio of N/A, whereas SHPG's P/E ratio is 11.35. In terms of profitability, SBFMW's ROE is -0.26%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, SBFMW is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for SBFMW.Check SHPG's competition here